Clinical Trials Browser

Phase 2 × Completed × Androgen-independent Prostate Cancer × Clear all

NCT00661492 2016-12-09

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)

Phase 2 Completed

115 enrolled 16 charts

Androgen-independent Prostate Cancer